Un cas de BCGéite atypique chez un patient diabétique

Medecine Therapeutique

Volumn 2, Issue 10, 1996, Pages 815-818

  Coumau, Édith ^a   Zylberberg, Hervé ^b  

^a Interne APHP ^*

^b HÔPITAL NECKER ENFANTS MALADES   (France)

Author keywords

[No Author keywords available]

Indexed keywords

BCG VACCINE; CYCLOSERINE; ETHAMBUTOL; GLICLAZIDE; ISONIAZID; METFORMIN; PREDNISOLONE; RIFAMPICIN;

AGED; ARTICLE; BLADDER CANCER; CASE REPORT; DIABETES MELLITUS; HUMAN; MALE; TUBERCULOSIS;

EID: 0030469047     PISSN: 12646520     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (11)

1. Maharaj B., et al. 1986. Sampling variability and its influence on the diagnostic yield of percutaneous needle biopsy of the liver. Lancet 8 : 523-525.
2. Brosman S.A. 1992. Bacillus Calmette-Guerin immunotherapy. Techniques and results. Urol Clin North Am 19 : 557-564
3. Lamm D.L., Stogdill V.D., Stogdill B.J., Crispen R.G. 1986. Complications of Bacillus Calmette-Guerin immunotherapy in 1 278 patients with bladder cancer. J Urol 135 : 272-274.
4. Lamm D.L., et al. 1992 Incidence and treatment of complications of Bacillus Calmette-Guerin intravesical therapy in superficial bladder cancer. J Urol 147 : 596-600.
5. Lamm L.D. 1992. Complications of Bacillus Calmette-Guerin immunotherapy. Urol Clin North Am 19 : 565-572.
6. Lotte A., et al. 1984. BCG complications : estimates of the risk among vaccinated subjects and statistical analysis of their main characteristics. Adv Tuberc Res 21 : 107.
7. Deutekom H.V. 1996. Bacillus Calmette-Guerin (BCG) meningitis in an AIDS patient 12 years after vaccination with BCG. Clin Infect Dis 22 : 870-871.
8. Van der Meijden A.P.M., Van Klingeren B., Steerenberg P.A., De Boer L.C., De Jong W.H., Debruyne F.M.J. 1991. The possible influence of antibiotics and tuberculostatics on : results of Bacillus Calmette-Guerin intravesical therapy for superficial bladder cancer. J Urol 14 : 144-146.
9. Boccafoshi C., Montefiore F., Pavesi M., Pastormerlo M., Betta P.G. 1995. Late effects of intravesical Bacillus Calmette-Guerin immunotherapy on bladder mucosa infiltrating lymphocytes : an immunohistochemical study. Eur Urol 27 : 334-338.
10. Cornel E.B., Van Moorselaar R.J.A., Van Stratum P., Debruyne F.M.J., Schalken J.A. 1993. Antitumour effects of Bacillus Calmette-Guerin in a syngeneic rat bladder tumour model system RBT. J Urol 149 : 179-182.
11. Rajala P., et al. 1992. Cytostatic effect of different straints of Bacillus Calmette-Guerin on human bladder cancer cells in vitro and in combination with mitomycine C and interferon alpha. Urol Res 20 : 215-217.